ALFA FinderNSE filing, NSE: SAROJA. Summary written from the filing by ALFA Finder's alert engine.
Saroja Pharma Industries India Ltd: key numbers
- Share price
- ₹38.00
- Market cap
- ₹15.28 Cr
- Revenue (annual)
- ₹70.13 Cr
- Net profit (annual)
- ₹1.61 Cr
- P/E (TTM)
- 9.5×Sector 29.3×
- Promoter holding
- 73.02%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Saroja Pharma Industries India Ltd
All →Saroja Pharma Industries India Management Change
Saroja Pharma's statutory auditor Pravin Chandak & Associates resigned effective October 26, 2026, citing pre-occupation. The company will appoint new auditors to fill the vacancy.
Saroja Pharma Industries India Management Change
Mr. Ravindra Shivaji Salaskar has resigned as Whole-time Director of Saroja Pharma Industries India Limited, effective October 5, 2026. He continues as the company's CFO.
Saroja Pharma Industries India Annual General Meeting
Saroja Pharma Industries India Limited held its 8th Annual General Meeting on September 30, 2026, through video conferencing to transact business.
Saroja Pharma Industries India Management Change
Saroja Pharma Industries India Limited appointed Mr. Ravindra Shivaji Salaskar as Chief Financial Officer. He currently serves as a Whole-time Director of the company.
Saroja Pharma Industries India Annual General Meeting
Saroja Pharma Industries India Limited has issued a notice for its 8th Annual General Meeting, scheduled to be held on September 30, 2026, through video conferencing.
Saroja Pharma Industries India Board Meeting Outcome
Saroja Pharma Industries approved its draft Board Report, Management Discussion and Analysis Report, and the notice for its 8th Annual General Meeting.
Other management change announcements
All →ICICI Prudential Asset Management Company Management Change
ICICI Prudential AMC disclosed that Senior Management Personnel Abhijit Shah opted for early retirement, effective close of business November 27, 2026. The change is a senior management departure.
India Glycols Management Change
India Glycols re-appointed Executive Director Alok Singhal for three years from 1 December 2026, subject to shareholder approval. He has served the company since 1991.
- Execution
- 3 years from 1 December 2026 to 30 November 2029
Bajaj Hindusthan Sugar Management Change
Bajaj Hindusthan Sugar's board approved by circular resolution an EGM to appoint Mrs. Priyanka Baya as an Independent Woman Director. It also approved the EGM notice, a scrutinizer and an e-voting agency.
Arvind SmartSpaces Management Change
Arvind SmartSpaces announced the resignation of Mr. Vishal Balesh, Chief Sales & Marketing Officer, effective 13 November 2026 after close of business. The resignation is to pursue a career opportunity outside the Group.
Laffans Petrochemicals Management Change
Laffans Petrochemicals appointed Swapna Shivashankaran as Company Secretary and Compliance Officer, effective 16 November 2026. It also removed secretarial auditor V Kumar & Associates, effective 13 November 2026.
Ceinsys Tech Management Change
Ceinsys Tech appointed Bala Pavan Kumar Tsunduru as President & Senior Management, effective 2026-12-07. Also reports a KMP designation change for Richa Jain (CFO/Deputy CFO).